ID: ALA5277393

Max Phase: Preclinical

Molecular Formula: C16H18O4

Molecular Weight: 274.32

Associated Items:

Representations

Canonical SMILES:  CC(c1ccc(O)c(O)c1)C(C)c1ccc(O)c(O)c1

Standard InChI:  InChI=1S/C16H18O4/c1-9(11-3-5-13(17)15(19)7-11)10(2)12-4-6-14(18)16(20)8-12/h3-10,17-20H,1-2H3

Standard InChI Key:  JNRHWIWTLPDOPG-UHFFFAOYSA-N

Associated Targets(Human)

Alpha-synuclein 10960 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 274.32Molecular Weight (Monoisotopic): 274.1205AlogP: 3.42#Rotatable Bonds: 3
Polar Surface Area: 80.92Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.17CX Basic pKa: CX LogP: 3.87CX LogD: 3.86
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.65Np Likeness Score: 0.52

References

1. Bernardes G, Munir O, Krol ES..  (2023)  The effect of diphenylethane side-chain substituents on dibenzocyclohexadiene formation and their inhibition of α-synuclein aggregation in vitro.,  78  [PMID:36587551] [10.1016/j.bmc.2022.117147]

Source